| Revenue growth | 16.2% YoY growth in revenue from operations |
|---|---|
| Margins | EBITDA margin softened to 19.3% from 22.2% YoY |
| Demand visibility | Strong footfall at Dombivli; healthy occupancy in established hospitals |
| Management confidence | High; citing steady occupancy ramp-up and insurance empanelment |
Growth
Revenue grew to Rs 411 Cr (up 16.4% YoY); EBITDA remained stable at Rs 79.3 Cr despite initial ramp-up losses.
Outlook
Scaling capacity from 1,700 to 2,900 beds via greenfield projects in Pune, Mira Road, and BKC.
Risks
EBITDA impacted by Rs 9.5 Cr Dombivli loss; higher interest and depreciation from ongoing expansion.
Last quarter's promises, checked
Delivered
- Dombivli commissioning by Q1 FY27 → delivered Feb 2026 (= BEAT)
- Dombivli EBITDA burn INR 2-3 Cr/month → delivered INR 3.1 Cr/month (= BEAT)
- Asset-heavy model capex ~INR 1.5 Cr/bed → delivered ~INR 1.5 Cr/bed (= BEAT)
Partly delivered
- Dombivli insurance empanelment 6-12 months → delivered ongoing Q1FY27 (= PARTIAL)
Investor Presentation filed with BSE, NSE: JLHL. Summary written with AI assistance from the document.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹265.65
- Market cap
- ₹8,709 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 46.4×Sector 57.8×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Management is optimistic as the new Dombivli hospital ramps up, despite it causing a 9.5 crore EBITDA drag this quarter.
Jupiter Life Line Hospitals Q1 FY27 Results: Net Profit ₹37.5 Cr, Down 14.6% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹411 Cr (+16.4% YoY) and net profit of ₹37.5 Cr (-14.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹37.5 Cr · -14.6% YoY
Jupiter Life Line Hospitals Earnings Call: Key Takeaways
Jupiter reports strong FY26 performance with 15.2% revenue growth to ₹1,499.8cr. Focus remains on greenfield expansion in Western India with asset-heavy ownership model.
Jupiter Life Line Hospitals Earnings Call: Key Takeaways
Jupiter is aggressively expanding in Western India, leveraging its asset-heavy model to build high-capacity flagship hospitals in Mumbai and Pune.